Viatris VTRS
NASDAQ VTRS
$17.46 -0.26 (-1.47%)
At close: Oct 1, 2026 · 4:00 PM EDT

Viatris (VTRS) Goodwill impairment charges (2024 - 2025)

Updated

Viatris (VTRS) recorded Goodwill impairment charges of $2.94 billion in FY2025, up 814.9% from $321 million in FY2024.

Analysis

Viatris (VTRS) Goodwill impairment charges (2024 - 2025) Analysis & Trends

  • Per Business Quant data, VTRS's Goodwill impairment charges was $321 million in FY2024 (-44.7%) and $580.1 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Viatris 20.35 Bn 15.36 Bn 1.46 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 2.94 Bn
Jun 30, 2024 321.00 Mn
API Access

Viatris Goodwill impairment charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=VTRS&period=max&api_key=YOUR_API_KEY